BETAPLUS, Bayer’s patients support program for Betaferon


BETAPLUS aims to encourage adherence in patients taking BETAFERON.


Adherence to medication is critical to ensure the effectiveness of healthcare [1]. Unfortunately, poor adherence to therapeutic regimens is widespread among patients with MS [1,2]. Taking an injectable must not be a barrier to adherence [2-5]. Supportive strategies are important [2,6]. Shared effort, a multi-disciplinary team approach and patient support programs have been shown to positively influence adherence [2,7-10].


BETAFERON’s patient support program BETAPLUS offers a variety of services to help promote adherence, including:


  • BETA nurses: nursing professionals specially trained to support MS patients taking BETAFERON throughout their entire treatment journey
  • Patient information materials such as training leaflets or videos
  • Modern autoinjectors including BETACONNECT


Patient services and their features may vary from country to country. Please contact your local Bayer affiliation for more details. 



  • World Health Organization. Adherence to long-term therapies: evidence for action. 2003. Available at: (accessed August 22, 2022). Return to content
  • Lugaresi A et al. Expert Rev Neurother 2014; 14(9): 1029-42. Return to content
  • Longbrake EE et al. Mult Scler J Exp Transl Clin 2016; 2: 2055217316677868. Return to content
  • Burks J et al. Clinicoecon Outcomes Res Actions 2017; 9: 251-60. Return to content
  • Mardan J et al. J Manag Care Spec Pharm. 2021;27(9):1273-95. Return to content
  • Sejbaek T et al. Mult Scler Rel Disord 2018; 24: 42-6. Return to content
  • Tan H et al. Mult Scler 2010; 16: 956-63. Return to content
  • Tan H et al. Adv Ther 2011; 28(1): 51-61. Return to content
  • Stockl KM et al. Am J Manag Care 2010; 16: 139-44. Return to content
  • DuChane J et al. J MS Care 2015; 17: 57-64. Return to content
Alt tag